Sierra Leone vs Suriname: Prevalence rate of hypertension in women aged 30-79
Sierra Leone
43.4
in 2019
Suriname
43.3
in 2019
Sierra Leone rank
31st
Suriname rank
32nd
Prevalence rate of hypertension in women aged 30-79 over time
- Sierra Leone
- Suriname
How they compare
Sierra Leone currently reports 43.4 against 43.3 in Suriname, a difference of 0.1.
Across all 30 years both countries report, Sierra Leone has been ahead every year.
Sierra Leone ranks 31st and Suriname ranks 32nd of 195 countries.
Sierra Leone has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sierra Leone | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 40.54 | 37.67 | 2.87 | Sierra Leone |
| 2000s | 43.32 | 40.12 | 3.2 | Sierra Leone |
| 2010s | 43.93 | 42.71 | 1.22 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Sierra Leone or Suriname?
- Sierra Leone, at 43.4 against 43.3 in Suriname as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Sierra Leone and Suriname?
- 0.1, with Sierra Leone ahead.
- How many years of comparable data are there for Sierra Leone and Suriname?
- 30 years are reported by both, from 1990 to 2019.
- How do Sierra Leone and Suriname rank globally for prevalence rate of hypertension in women aged 30-79?
- Sierra Leone ranks 31st and Suriname ranks 32nd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.